Many other prognostic factors such as tumor-related gene expression patterns, immune-related tumor micro-environment,the extent of tumor resection, performance status, nutritional status, and mutations (e.g. IDH1/2 mutation or MGMT methylation) could not have been reliable investigated and controlled for, mainly due to lack of data24–29. This evidence concerns the gene IDH1 and neoplasm.